Clinical trial
Analysis of Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia
Name
21-10024054
Description
The purpose of this study is to assess the safety and efficacy of ropivacaine and hydrocodone for nail-procedure associated pain management. The investigators hypothesize that ropivacaine with hydrocodone will be superior to ropivacaine with acetaminophen and ibuprofen for managing pain.
Trial arms
Trial start
2022-11-10
Estimated PCD
2023-05-15
Trial end
2023-06-01
Status
Completed
Phase
Early phase I
Treatment
Hydrocodone 5Mg/Acetaminophen 325Mg Tab
5 mg/325 mg tablet
Arms:
Hydrocodone 5mg/acetaminophen 325mg
Other names:
Vicodin, Norco, Lortab
Acetaminophen 1000mg
1000 mg tablet
Arms:
Acetaminophen 1000mg + Ibuprofen 400mg, Hydrocodone 5mg/acetaminophen 325mg
Other names:
Tylenol
Ibuprofen 400 mg
400 mg tablet
Arms:
Acetaminophen 1000mg + Ibuprofen 400mg, Hydrocodone 5mg/acetaminophen 325mg
Other names:
Advil, Motrin
Size
20
Primary endpoint
Change From Baseline in Pain Scores on Postoperative Day 2, as Measured by the Wong-Baker 0-to-10 Pain Scale
Baseline, 2 days
Eligibility criteria
Inclusion Criteria:
* Patients undergoing fingernail or toenail, excision, or shave biopsy
* Must understand and voluntarily sign an informed consent form
* Must be male or female and aged 18-95 years at time of consent
* Must be able to adhere to the study visit schedule and other protocol requirements
Exclusion Criteria:
* Subject is unable to provide written informed consent for any reason
* Subject has peripheral vascular disease, arterial insufficiency, peripheral neuropathy
* Subject is on Aspirin, NSAIDs, or consumes a chronic medication for control of any other chronic pain
* Subject has a history of opioid or alcohol use disorder
* Subject has a history of peptic ulcer disease, gastritis, chronic renal insufficiency or a history of kidney disease, or has underlying liver disease
* Subject has a history of severe constipation
* Subject is sensitive or allergic to any of the elements included in this study
* Subject is unable to complete the required pain dairy
* Subject is pregnant, planning pregnancy, or nursing
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 20, 'type': 'ACTUAL'}}
Updated at
2023-09-28
1 organization
3 products
2 indications
Organization
Weill Medical College of Cornell UniversityProduct
Hydrocodone/AcetaminophenIndication
Nail DiseasesIndication
Nail AbnormalitiesProduct
AcetaminophenProduct
Ibuprofen